We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Cencora Inc (COR) Com Stk NPV

Sell:$245.60 Buy:$245.61 Change: $2.20 (0.90%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Ex-dividend
Sell:$245.60
Buy:$245.61
Change: $2.20 (0.90%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Ex-dividend
Sell:$245.60
Buy:$245.61
Change: $2.20 (0.90%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

Contact details

Address:
1 West First Avenue
CONSHOHOCKEN
19428
United States
Telephone:
+1 (610) 7277000
Website:
https://www.cencora.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
COR
ISIN:
US03073E1055
Market cap:
$47.92 billion
Shares in issue:
197.05 million
Sector:
Health Care Distributors
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Steven Collis
    Executive Chairman of the Board
  • Robert Mauch
    President, Chief Executive Officer, Director
  • James Cleary
    Chief Financial Officer, Executive Vice President
  • Silvana Battaglia
    Chief Human Resource Officer, Executive Vice President
  • Pawan Verma
    Executive Vice President, Chief Data and Information Officer
  • Elizabeth Campbell
    Executive Vice President and Chief Legal Officer
  • Leslie Donato
    Executive Vice President and Chief Strategy Officer
  • Francois Mandeville
    Executive Vice President - Strategy and M&A

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.